Visit SciVerse ScienceDirect to see if you have access via your institution.
More periodicals:
HIGHLIGHTS OF A SYMPOSIUM: Managing Symptomatic Menopausal Women With Medical Complications
This Highlights of a Symposium is supported by an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc., and was jointly sponsored by Excerpta Medica, Inc., an ACCME accredited provider, and Ob.Gyn. News.
Articles are based on presentations given at a continuing medical education symposium held in Philadelphia on May 2, 2004.
To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 5.
Faculty
Introduction
Morris Notelovitz, MD, PhD
Consultant, Adult Women's Health and Medicine
Boca Raton, FL Nothing to disclose.
The Aging Menopausal Woman and the Need to Treat
Morris Notelovitz, MD, PhD
Measuring Risk and Treating Vasomotor Symptoms in Menopausal Women With Cardiovascular Complications
Thomas Dayspring, MD
Clinical Assistant Professor of Medicine
University of Medicine and Dentistry of New Jersey
New Jersey Medical School
Newark Discusses the unlabeled use of estrogen and progestogens in their effects on lipids.
Using Hormone Therapy in the Menopausal Patient With Risk of Breast Cancer
Raquel D. Arias, MD
Associate Professor, Obstetrics and Gynecology
Associate Dean for Women
University of Southern California
Keck School of Medicine
Women's and Children's Hospital
Los Angeles Consultant: Barr Laboratories, Inc., Berlex Laboratories, Novo Nordisk Pharmaceuticals, Inc., Organon, Inc., Ortho-McNeil Pharmaceutical, Inc., Watson Pharmaceuticals, Inc., and Wyeth Pharmaceuticals.
Assessing the Menopausal Women
Valerie Montgomery Rice, MD
Professor and Chair
Department of Obstetrics & Gynecology
Meharry Medical College
Nashville, Tenn. Consultant: Eli Lilly and Company, National Institutes of Health, and Wyeth.
Target Audience
This activity has been developed for obstetrician/gynecologists and other health care professionals who treat peri- and postmenopausal patients.
Educational Needs
The issue of whether to use hormone therapy (HT) to manage menopause-associated conditions such as vasomotor symptoms, rapid bone loss, and vaginal atrophy is a complex one, complicated by conflicting evidence regarding potential health risks that have been demonstrated in several recent clinical trials. The physician needs to be aware of not only these recent research findings but also the various risk assessment tools available and the differing effects that common HT formulations may have on patients' lipid profiles and other metabolic parameters. Such information is essential for the physician and patient to make informed choices on therapeutic options based on each woman's distinctly individual health and risk profile.
Learning Objectives
By reading and studying this supplement, participants should be able to:
• Discuss the potential risks and benefits of HT, especially in light of the findings of the estrogen-only component of the Women's Health Initiative.
• List at least four assessment tools that can be helpful in evaluating the health status of a woman in early menopause.
• Describe the positive and negative effects various HT formulations may have on patients' triglyceride levels and the ramifications of this for patients at higher risk for cardiovascular complications.
• Summarize the findings of the major studies that have examined the effect of estrogen monotherapy on breast cancer risk.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Excerpta Medica, Inc., and Ob.Gyn. News. Excerpta Medica is accredited by the ACCME to provide continuing medical education for physicians.
Excerpta Medica designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
The American Medical Association has determined that non-US licensed physicians who participate in this activity are eligible for AMA/Physician's Recognition Award category 1 credit.
